| Diclofenac Potassium |
Capsule |
II (Paddle |
50 |
50 mM Phosphate buffer pH 6.8 |
900 |
10, 15, 20, 30 and 45 |
2010/10/21 |
| Diclofenac Potassium |
Tablet |
II (Paddle) |
50 |
SIF without enzyme |
900 |
10, 20, 30, 45, 60 and 90 |
2004/01/27 |
| Diclofenac Sodium |
Tablet (Extended Release) |
|
|
Refer to USP |
|
|
2009/06/10 |
| Diclofenac Sodium |
Tablet (Delayed Release) |
|
|
Refer to USP |
|
|
2009/06/10 |
| Diclofenac Sodium/Misoprostol Enteric Coated |
Tablet (Delayed Release) |
II (Paddle)
(diclo) |
100 (diclo) |
Diclofenac:
Acid Stage: 0.1 N HCl
Buffer Stage: 750ml 0.1N HCL+250ml 0.2M phos.buffer, pH 6.8 (Method A)
Misoprostol: Develop a dissolution method |
Diclo: Acid: 750
Buffer:1000 |
Diclo.:
120 (acid)
15, 30, 45 and 60 (Buffer) |
2023/09/15 |
| Dicloxacillin Sodium |
Capsule |
|
|
Develop a dissolution method |
|
|
2024/01/03 |
| Dicyclomine Hydrochloride |
Tablet |
|
|
Refer to USP |
|
|
2022/05/12 |
| Didanosine |
Tablet (Chewable) |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
| Didanosine |
Capsule (Delayed Release Pellets) |
I (Basket) |
100 |
Acid stage: 0.1 N HCl; Buffer stage: 0.1 N HCl:0.2M Tribasic Sodium Phosphate (3:1), pH 6.8 |
1000 |
Acid stage: 60, 90 and 120; Buffer stage: 10, 20, 30, 45 and 60 |
2004/01/26 |
| Dienogest/Estradiol Valerate |
Tablet |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
| Diethylpropion HCl |
Tablet (Extended Release) |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
| Diflunisal |
Tablet |
|
|
Refer to USP |
|
|
2008/04/15 |
| Digoxin |
Tablet |
|
|
Refer to USP |
|
|
2007/06/18 |
| Diltiazem HCl |
Tablet (Extended Release) |
II (Paddle) |
100 |
Phosphate Buffer, pH 5.8 |
900 |
2, 8, 14, and 24 hours |
2008/02/19 |
| Diltiazem HCl |
Capsule (Extended Release) |
|
|
Develop a dissolution method |
|
|
2024/01/03 |
| Dimethyl Fumarate |
Capsule (Delayed Release) |
II (Paddle) |
100 |
Acid stage: 0.1 N HCl; Buffer stage: pH 6.8 Phosphate Buffer |
Acid stage: 500; Buffer stage: 500 |
Acid stage: 2 hours; Buffer stage: 5, 10, 20, 30 and 45 |
2016/06/02 |
| Dinoprostone |
Vaginal Suppository |
|
|
Develop a method to characterize in vitro release |
|
|
2012/10/04 |
| Dinoprostone |
Vaginal Insert (Extended Release) |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
| Diphenhydramine Citrate/Ibuprofen |
Tablet |
II (Paddle) |
50 |
50 mM Phosphate Buffer, pH 6.5 |
900 |
10, 20, 30 and 45 |
2008/01/14 |
| Diphenhydramine HCl/Ibuprofen |
Capsule |
I (Basket) |
100 |
200 mM Phosphate Buffer, pH 7.2 |
900 |
10, 20, 30 and 45 |
2008/01/14 |